Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of FTY720 in De Novo Kidney Transplant Recipients
NCT00099801Phase 3Completed
- Sponsor
- Novartis
- Start
- Jan 2005
- Primary completion
- Mar 2006
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of fingolimod in kidney transplant rejection, sponsored by Novartis. Started Jan 2005; status: completed.
02
Drugs
fingolimod
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00099801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00099801.